Urinary tract infection (UTI), a frequent and important disease in humans, is primarily caused by uropathogenic Escherichia coli (UPEC). UPEC forms acute cytoplasmic biofilms within superficial urothelial cells and can persist by establishing membrane-enclosed latent reservoirs to seed recurrent UTI. The host responds with an influx of innate immune cells and shedding of infected epithelial cells. The autophagy gene ATG16L1 has a commonly occurring mutation that is associated with inflammatory disease and intestinal cell abnormalities in mice and humans. Here, we show that Atg16L1-deficient mice (Atg16L1 HM ) cleared bacteriuria more rapidly and thoroughly than controls and showed rapid epithelial recovery. Atg16L1 deficiency was associated with a potent proinflammatory cytokine response with increased recruitment of monocytes and neutrophils to infected bladders. Chimeric and genetic studies showed that Atg16L1 HM hematopoietic cells alone could increase clearance and that Atg16L1-deficient innate immune cells were required and sufficient for enhanced bacteriuric clearance. We also show that Atg16L1-deficient mice exhibit cell-autonomous architectural aberrations of superficial urothelial cells, including increases in multivesicular bodies, lysosomes, and expression of the UPEC receptor Up1a. Finally, we show that Atg16L1 HM epithelial cells contained a significantly reduced number of latent reservoirs. Together, our results show that Atg16L1 deficiency confers protection in vivo to the host against both acute and latent UPEC infection, suggest that deficiency in a key autophagy protein can be protective against infection in an animal model of one of the most common diseases of women worldwide, and may have significant clinical implications for understanding the etiology of recurrent UTIs.
Urinary tract infection (UTI), a frequent and important disease in humans, is primarily caused by uropathogenic Escherichia coli (UPEC). UPEC forms acute cytoplasmic biofilms within superficial urothelial cells and can persist by establishing membrane-enclosed latent reservoirs to seed recurrent UTI. The host responds with an influx of innate immune cells and shedding of infected epithelial cells. The autophagy gene ATG16L1 has a commonly occurring mutation that is associated with inflammatory disease and intestinal cell abnormalities in mice and humans. Here, we show that Atg16L1-deficient mice (Atg16L1 HM ) cleared bacteriuria more rapidly and thoroughly than controls and showed rapid epithelial recovery. Atg16L1 deficiency was associated with a potent proinflammatory cytokine response with increased recruitment of monocytes and neutrophils to infected bladders. Chimeric and genetic studies showed that Atg16L1 HM hematopoietic cells alone could increase clearance and that Atg16L1-deficient innate immune cells were required and sufficient for enhanced bacteriuric clearance. We also show that Atg16L1-deficient mice exhibit cell-autonomous architectural aberrations of superficial urothelial cells, including increases in multivesicular bodies, lysosomes, and expression of the UPEC receptor Up1a. Finally, we show that Atg16L1 HM epithelial cells contained a significantly reduced number of latent reservoirs. Together, our results show that Atg16L1 deficiency confers protection in vivo to the host against both acute and latent UPEC infection, suggest that deficiency in a key autophagy protein can be protective against infection in an animal model of one of the most common diseases of women worldwide, and may have significant clinical implications for understanding the etiology of recurrent UTIs.
Atg5 | Lyz-Cre | Rag1 M acroautophagy (henceforth, autophagy) is a well-conserved cellular pathway required to maintain cellular homeostasis, recycle cellular components, and eliminate intracellular pathogens (1, 2) . In response to nutrient deprivation, stress, or other signals, double membrane-bound autophagosomes are recruited to envelop bulk cytoplasm, damaged organelles, large cytoplasmic protein aggregates, or invading pathogens. These autophagosomes then fuse with lysosomes, and therefore, their cargo may be degraded. Autophagy genes and proteins play a multiplicity of roles in both innate and adaptive immunity (3) (4) (5) . For example, in mice deficient for Atg5 in macrophages and neutrophils, there is increased susceptibility to infection with Listeria monocytogenes and Toxoplasma gondii, and Atg5 deficiency is associated with decreased resistance to viral encephalitis (6, 7) . Pathogens have also evolved sophisticated mechanisms to evade or subvert the host autophagy machinery for survival and persistence within cells (8) by blocking the xenophagic degradation of intracellular pathogens or the function of autophagy in innate and adaptive immunity. Although most work to date shows that autophagy as a whole and specific autophagy proteins are detrimental to the microorganism, they may also have proviral or probacterial effects. For example, autophagosomes may serve as a protected niche for intracellular bacteria and/or source of nutrients for intracellular pathogens (9) . In vivo evidence of such a propathogen role of autophagy is still lacking.
The autophagy gene/protein Atg16L1 plays a key role in autophagosome maturation as part of a protein complex that directs the microtubule-associated protein light chain 3 (LC3) to autophagosomes en route to their fusion with lysosomes (1, 10). We previously showed that mice deficient in Atg16L1 (Atg16L1 HM ) display reduced autophagy. In addition, they develop, on viral infection, intestinal abnormalities similar to pathologies found in Crohn's disease patients, including abnormalities in the integrity, architecture, and function of Paneth cells, which are specialized secretory epithelial cells of the small intestine (11, 12) . Atg16L1 has also been shown to play a role in modulating proinflammatory responses in mice and humans (13, 14) . Furthermore, population genetic studies have positively associated a common polymorphism in the ATG16L1 gene with inflammatory bowel disease (15, 16) . One explanation for a high prevalence of such harmful gene variants would be protection from common infections. However, such a protective role for mutation of an autophagy gene has not been reported.
Here, we use Atg16L1 HM mice as a genetically tractable model to determine whether mutation in an autophagy gene can increase resistance to a common infection. Urinary tract infections (UTIs), primarily caused by uropathogenic Escherichia coli (UPEC), are among the most common infectious diseases in humans, resulting in an estimated 13 million outpatient visits yearly in the United States (17) . Recurrent UTIs are a serious problem, with ∼25% of patients experiencing multiple episodes per year despite appropriate antibiotic treatment and absence of bacteriuria between episodes (18) . In an in vivo mouse model, UPEC invades bladder superficial cells by binding uroplakin receptors expressed on the cell surface (19, 20) . During the acute stage of infection (0-72 h), intracellular UPEC replicates rapidly and establishes cytoplasmic biofilms termed intracellular bacterial communities (IBCs) in bladders of both mice and humans (21, 22) . Major mechanisms for control of UPEC-induced UTI include exfoliation of the superficial epithelial cell layer containing IBCs into the urine and influx of innate immune cells (23) (24) (25) (26) . However, despite the innate immune host response, a subset of UPEC still survives and establishes long-term reservoirs within urothelial cells, termed quiescent intracellular reservoirs (QIRs) (27) , which are enclosed within vesicles decorated with late endosomal/lysosomal markers. Latent UPEC within QIRs can reemerge to seed recurrent UTIs likely through cAMPregulated exocytic processes to reenter the bladder lumen concomitant with urothelial regeneration (27) (28) (29) .
Results
Atg16L1 Deficiency Leads to Superficial Cell Architectural Abnormalities.
To determine if Atg16L1 plays a role in UPEC invasion and persistence within the bladder, we first examined the morphology of superficial urothelial cells, the target cells for UPEC invasion, in Atg16L1 HM mice. These cells are highly specialized to rapidly expand and shrink as the bladder fills and contracts, and this function requires large plaques of hexagonal arrays of uroplakin protein complexes, which are transported by discoidal fusiform vesicles (FVs) and multivesicular bodies (MVBs) to maintain cellular architecture and barrier properties (30, 31) . UPEC uses the uroplakins (Up1a) as receptors to facilitate invasion and entry into these urothelial cells (30) (31) (32) . We reasoned that Atg16L1 deficiency might alter this membranous intracellular network, because changes in intracellular membranes associated with granule exocytosis are observed in the intestinal Paneth cell in Atg16L1 HM mice (11) . Here, we show that Atg16L1 deficiency governs urothelial cell architecture as follows. First, bladders of Atg16L1 HM mice exhibited decreased (by 78%) Atg16L1 expression (Fig. S1) . Second, superficial epithelial cells of uninfected Atg16L1 HM mice showed dramatic accumulation of vesicles (Fig. 1B) compared with those cells of control (WT) mice (Fig. 1A) . Transmission EM (TEM) confirmed this vesicular congestion ( Fig. 1 C-F and Fig. S2 A-C) and revealed significantly greater numbers of organelles with the morphology of MVBs and lysosomes in Atg16L1 HM superficial cells ( Fig. 1 G and H) (P < 0.05 and P < 0.01, respectively). Third, given that this vesicular system is responsible for uroplakin transport and recycling and that disruption in vesicular trafficking of FVs and MVBs is associated with aberrant MVB accumulation (28, 30, 33) , we next determined the effect of Atg16L1 deficiency on uroplakin receptor expression. We found increased Up1a expression in Atg16L1
HM bladders ( Fig. 1 I and J), correlating with the increased MVBs seen by TEM in Atg16L1
HM superficial cells. These data show that Atg16L1 is a key player in modulating and/or maintaining the proper architecture of superficial cells, including membranes that are involved in uroplakin expression.
Autophagy Machinery Intersects with UPEC. The autophagy pathway functions to sequester intracellular pathogens after cellular invasion through recognition and decoration by LC3 and an adaptor protein p62 (1, 9, 34, 35) . To determine whether such autophagyassociated pathogen recognition is engaged on UPEC infection in vivo, we infected bladders of adult female WT mice by transurethral inoculation of a clinical cystitis isolate UTI89 (36) . On UPEC invasion of bladder superficial cells, Atg16L1 and LC3 puncta colocalized with UPEC within IBCs at 6 h postinoculation (hpi) and QIRs at 14 d postinoculation (dpi) (Fig. S3 A-D and A-D Insets). p62 puncta, normally present throughout the urothelium in an uninfected state (Fig. S3E) , were recruited to the site of bacterial entry (Fig. S3F) . Thus, autophagy proteins associate with UPEC during the acute and latent stages of UPEC pathogenesis in vivo.
Atg16L1 Deficiency Leads to Rapid Clearance of Bacteriuria and
Significant Reduction in Latent Reservoirs. To determine if Atg16L1 deficiency-induced alterations in superficial urothelial cell morphology and increased uroplakin expression affect UPEC invasion and persistence in superficial urothelial cells, we induced a UTI in adult female control and Atg16L1 HM mice. The progress of UPECinduced UTI was monitored by measuring shedding of bacteria into the urine (i.e., bacteriuria), analyzing bacterial invasion and colonization in the bladder tissue, and evaluating the number of QIRs. We found that UPEC invaded and colonized the bladders of Atg16L1 HM and control mice during the acute infection stage (6 hpi) at similar levels ( Fig. 2 A and B) . Strikingly, however, as early as 1 dpi, Atg16L1 HM mice exhibit significantly reduced bacteriuria ( Fig. 2A ) and bladder tissue UPEC titers (Fig. 2B) , and thus, they were more effective at clearing bacteriuria than controls (P < 0.01). We also show that this enhanced bacteriuric clearance can be induced even in the presence of one hypomorphic Atg16L1 allele: Atg16L1 HM heterozygote mice expressing 41% of Atg16L1 protein (Fig. S1 ) cleared UPEC faster compared with control mice by 3 dpi (P < 0.05) (Fig.  S4) . Thus, the presence of a single hypomorphic Atg16L1 allele is sufficient to confer protection from bacterial infection.
Given the abnormal accumulation of MVBs in the superficial bladder epithelial cells of Atg16L1 HM mice, we investigated whether these epithelial changes were altering early invasion events, leading to the decreased bacterial burden. Examination at 6 hpi for IBC formation (Fig. 2C) showed similar numbers of IBCs in Atg16L1 HM and control bladders (Fig. 2D) , consistent with similar urine and ) (E and F) High magnification image of WT (E) and HM (F) superficial cells displaying fusiform vesicles (FVs; blue arrow), multivesicular bodies (MVBs; red arrow), and lysosomes (LYs; yellow arrow). (Scale bar: 1 μm.) (G and H) Quantification of MVBs (G) and lysosomes (H) showing a significant increase in HM urothelium. Bars represent mean ± SEM. *P < 0.05, **P < 0.01 by unpaired two-tailed t test. (I and J) Western blot (I) of whole-bladder protein indicates increased UP1a in HM mice relative to WT mouse (normalized to GAPDH) and quantification of UP1a expression relative to WT (J). Bars represent mean ± SEM. **P < 0.01 by unpaired two-tailed t test.
bladder bacteria titers at 6 hpi. Thus, decreased Atg16L1 expression in Atg16L1
HM bladders is associated with decreased bacteriuria, which is not caused by alteration of early epithelial invasion and colonization events.
We next examined control and Atg16L1 HM bladders at 14 dpi to determine if enhanced acute clearance of bacteriuria from the bladders of Atg16L1 HM mice was associated with reduced establishment of QIRs. QIRs can seed recurrent infection, although the reservoirs contain relatively small numbers of bacteria that are often at or below detection levels in urine and bladder cfu titers (27) . We found that bladders of Atg16L1 HM mice harbored significantly reduced numbers of Lamp1+ QIRs compared with bladders of control mice (Fig. 2 E-G) (P < 0.05). Thus, Atg16L1 deficiency resulted in increased resistance to the formation of protected niches containing UPEC during the latent stage of infection. Together, our data show that Atg16L1 deficiency is associated with decreased bacteriuria and bladder colonization by UPEC at acute stages of infection and protection from UPEC latency.
Superficial Urothelial Cell Regeneration Is Hastened in Atg16L1-Deficient Bladders. Urothelial tissue regeneration is an important step in the resolution of UTIs (37) . We analyzed bladder tissue sections from control and Atg16L1 HM mice at 6 and 14 dpi and found that, relative to uninfected bladders from control and Atg16L1 HM mice (Fig. S5 A and B) , the bladders of control mice at 6 dpi displayed persistent stromal inflammation and proliferating transitional epithelial cells (Fig. S5C, arrow) . In contrast, Atg16L1
HM bladders displayed newly regenerated, terminally differentiated, and nonproliferating superficial cells (Fig. S5D, arrow) and resolution of inflammation (Fig. S5D) . By 14 dpi, both control and Atg16L1
HM bladders displayed regenerated superficial cells ( Fig. S5 E and F) , but bladders of control mice continued to show inflammation (Fig. S5E, arrowheads) . The proliferative index of stem/progenitor cells after infection was similar between control and Atg16L1 HM mice at 6 dpi ( Fig. S5G) , suggesting that the stem cell niche was unaffected by Atg16L1 deficiency. However, by 14 dpi, although continued proliferative activity was observed in bladders of control mice (Fig. S5E, arrow) , it had returned to basal levels in bladders of Atg16L1 HM mice (Fig. S5 F and H) (P < 0.05). Thus, early bacterial clearance in Atg16L1 HM mice correlated with faster epithelial recovery. Interestingly, TEM analysis of WT and Atg16L1 HM bladders at 14 dpi (Fig. S6) confirmed that the regenerated superficial cells in Atg16L1 HM bladders also exhibited the ultrastructural vesicular defects observed before infection, suggesting Atg16L1 deficiency-induced cellular abnormality in superficial cells was autonomous to this cell type.
Atg16L1 Deficiency in the Hematopoietic Compartment Contributes
Significantly to Clearance of Bacterial Load. We next sought to determine the cellular mechanisms underlying the enhanced clearance of bacteria in Atg16L1 HM bladders and the resulting host-protective outcome. Previous work has shown that both hematopoietic and epithelial compartments are required to mount an efficient host response to UPEC infection in the bladder (24) . Although Atg16L1 deficiency in the epithelial compartment affected latent UPEC reservoir establishment, it did not show any differences in acute infection events (e.g., in IBC formation) that could explain the more rapid clearance in Atg16L1 HM mice. Furthermore, Atg16L1 plays a role in modulating proinflammatory responses (5, 13, 14) . We reasoned, therefore, that Atg16L1 deficiency in immune cells could contribute to UPEC clearance directly by a potent proinflammatory response or indirectly by inducing the aberrant superficial urothelial cell architecture.
To elucidate contributions of Atg16L1 deficiency in hematopoietic cells to clearance of UTI, we generated reciprocal bone marrow chimera (Fig. 3 A-D) . To examine the contribution of the Atg16L1 hypomorphic hematopoietic compartment, we compared WT recipients receiving Atg16L1 HM bone marrow with those recipients receiving WT bone marrow. We show that WT mice receiving Atg16L1 HM bone marrow cleared bacteriuria faster: significantly more complete clearance was evident at 7 and 14 dpi as indicated by the lower bacteriuria titers in the presence of Atg16L1 HM bone marrow (Fig. 3E) . Differential interference contrast (DIC) imaging and TEM analysis revealed no aberrant changes in the epithelium of these WT animals, suggesting that Atg16L1 HM hematopoietic cells do not contribute to the superficial epithelial cell abnormalities (Fig. S7) , consistent with those abnormalities being cell autonomous; however, the presence of Atg16L1 HM bone marrow alone is sufficient for faster clearance of UTI infection.
Next, we sought to determine if Atg16L1 deficiency in the epithelium would contribute to the bacteriuric clearance and compared mice with WT and Atg16L1 HM epithelium receiving WT bone marrow. As expected, urothelial architectural abnormalities similar to those abnormalities described in Atg16L1 HM mice were observed in the bladders of Atg16L1 HM recipients receiving WT bone marrow (Fig. S7) ; however, these mice did not display faster clearance of bacteriuria (Fig. 3F) . Our findings indicate that the Atg16L1-deficient hematopoietic compartment is necessary for the clearance, that Atg16L1 deficiency in the epithelium alone with a WT hematopoietic compartment is not sufficient for faster luminal clearance, and that Atg16L1 deficiency-induced epithelial architectural abnormality is not regulated by Atg16L1 deficiency in hematopoietic cells. 
/Atg16L1
HM mice were more efficient in clearing infection as evidenced by significantly lower urine bacterial titers 7 (P < 0.05) and 14 (P < 0.01) dpi (Fig. S8) . Thus, our data suggest that, in the absence of an intact adaptive immune system, the Atg16L1 HM innate immune system is sufficient to lower the bacterial load.
Innate immune cells, particularly macrophages and neutrophils, constitute an early line of defense against UPEC infection in vivo (25) . We reasoned that Atg16L1 deficiency in these cells might contribute to the observed fast clearance of bacteriuria. This clearance could be achieved by increased recruitment of the innate immune cells to the bladder lumen to clear infection in Atg16L1 HM mice, and/or increased proinflammatory cytokine expression by Atg16L1
HM innate immune cells. We tested these hypotheses as follows. First, we examined the urines of Atg16L1 HM mice at acute stages of infection (6 and 24 hpi) and found that urines from Atg16L1 HM mice contained significantly higher numbers of neutrophils (Fig. 4A, 6 hpi) and monocytes on infection (Fig. 4B, 24 hpi). Next, we determined the proinflammatory cytokine response to infection in Atg16L1 HM mice. We conducted quantitative RT-PCR assays of bladder tissues as well as Bioplex assays of sera from infected control and Atg16L1 HM mice. We found significant increases in tissue IL-6 mRNA levels (Fig. 4C) (P < 0.05) and serum IL-1α levels 6 hpi (Fig. 4D) 
HM mice relative to control mice that were not noted before infection (Fig.  S9) . Together, our data show that Atg16L1 deficiency in the innate immune compartment is associated with increased recruitment of innate immune cells and a more robust proinflammatory response to infection.
To further dissect the role for autophagy protein deficiency in innate immune cells during a UTI, we used a mouse model that we previously generated (Atg5 fl/fl -Lyz-Cre mice, which are deficient in the autophagy protein Atg5 specifically in macrophages and granulocytes) (39) . We evaluated Atg5 in this system, because Atg5 is an essential autophagy protein that forms a part of the Atg16L1-containing protein complex essential for autophagy (1) . Consistent with Atg16L1 deficiency in immune cells causing enhanced clearance of infection, the Atg5 fl/fl -Lyz-Cre mice also resolved bacteriuria more rapidly than controls by 3 dpi (Fig. 4E) (P < 0.05). Furthermore, bladders of Atg5 fl/fl -Lyz-Cre mice did not exhibit evidence of organelle congestion or aberrant uroplakin receptor expression in the epithelium (Fig. S10) . Thus, Atg5 protein deficiency in macrophages and granulocytes resulted in enhanced control of bacterial infection without indirect effects on the epithelium.
Together, our data show that Atg16L1 deficiency specifically in innate immune cells is the mechanism of enhanced clearance of bacteria from the urine. Atg16L1 deficiency is associated with increased recruitment of innate immune cells to the infected bladders and a robust proinflammatory response, which likely modulates the rapid UPEC clearance in Atg16L1 HM mice. This response is elicited even in the absence of an adaptive immune system. Finally, deficiency of another autophagy pathway protein, Atg5, exclusively in innate immune cells is sufficient to induce rapid UPEC clearance.
Discussion
Autophagy has been recognized as an important defense system to combat intracellular pathogens and hitherto, considered to play an antipathogenic role. Here, we use an in vivo model of a common infectious disease and describe a propathogen role for an autophagy protein. We show that deficiency in the key autophagy protein, Atg16L1, can confer protection against a nonobligate intracellular pathogen, UPEC, which causes recurrent UTIs and has been shown to have both intracellular and extracellular stages in its pathogenic cycle. Atg16L1 HM mice clear bacteriuria faster and renew their epithelial barrier faster. We show that this protection is mainly caused by effects of Atg16L1 deficiency in hematopoietic cells and specifically, macrophages and neutrophils that are the main cellular drivers of the fast clearance of bacteriuria. Our findings suggest the presence of a more potent innate immune system in Atg16L1 HM mice with substantially increased proinflammatory cytokine expression as well as increased recruitment of innate immune cells to infected Atg16L1 HM bladders. We have previously showed enhanced transcription of proinflammatory cytokines and adipokines in Paneth cells of Atg16L1 HM mice (11) . Recently, the work by Lee et al. (14) delineated that Atg16L1 expression restricts IL-1β signaling cascades and the subsequent inflammatory response, such as IL-6 production, by constitutive autolysosomal and proteosomal degradation of p62; thus, the absence of Atg16L1 leads to a hyperinflammatory response. In the setting of Crohn's disease, Atg16L1 deficiency induces elevated proinflammatory cytokine levels, and the presence of commensal bacteria leads to intestinal pathology (12) . In the Atg16L1-deficient urinary tract, however, the elevated proinflammatory cytokine levels may have a beneficial effect-to better combat UPEC infection. We speculate that the more effective innate immune compartment in Atg16L1 HM mice may promote rapid elimination of bacteria, which may prevent additional bacterial invasion into underlying urothelial cells and result in faster clearance of bacterial load (23, 24, 40) , leading to restoration of a normal urothelium (41) . UPEC has been shown previously to inhibit proinflammatory cytokine production after invasion into epithelial cells (23) . Loss of Atg16L1 may impact the ability of UPEC to dampen the innate immune response resulting in the enhanced clearance. Together, our data all point to a protective role for the Atg16L1-deficient innate immune compartment in UTI.
Complex membrane recycling events in superficial urothelial cells play an important role in UPEC pathogenesis. Atg16L1 deficiency was associated with striking abnormalities in the accumulation of multivesicular bodies, lysosomes, and Up1a receptor in Atg16L1 HM mice-all components of the epithelial cells that UPEC interacts with during infection. These abnormalities seem intrinsic to the Atg16L1-deficient epithelial cells, because autophagy protein deficiency in hematopoietic cells does not generate these abnormalities; these defects are found even in newly regenerated superficial cells. To our surprise, early invasion and colonization of the bladder were not dramatically altered by the Atg16L1 deficiency-induced urothelial ultrastructural changes. Strikingly, however, in the presence of these abnormalities, or perhaps because of them, UPEC seems less able to occupy the intracellular niches to persist within the urothelium as QIRs. Thus, our findings suggest that UPEC may subvert Atg16L1 and possibly other autophagy proteins to establish latency. Recent in vitro evidence supports our model. For example, the work by Starr et al. (42) showed in vitro that Brucella subverts autophagy complexes to facilitate its intracellular cycle and showed that Brucella selectively co-opts autophagy initiation complexes to subvert host clearance and promote infection.
Our findings using the hypomorphic Atg16L1 mouse model reveal a striking benefit of Atg16L1 deficiency and suggest that deficiency in an autophagy gene that can promote inflammatory disease also protects against acute UTIs. This finding leads us to speculate that ATG16L1 allelic variants in the human population or other variants in autophagy-associated genes might be under positive selection for their ability to protect from UTIs.
Delineating mechanisms of intracellular persistence during a UTI is critical to developing effective strategies for preventing recurrent UTIs. Traditional antibiotics are unable to penetrate bladder epithelial barriers, and therefore, bacteria sequestered in QIRs can survive long term in protected niches. In addition, antibiotic therapy itself risks driving the pathogens into quiescence (43) . Targeting and eliminating the small but significant intracellular pool of bacteria may have substantial clinical benefits to combat refractory and recurrent UTIs. Thus, our model provides a system for investigating the role for autophagy proteins in pathogenesis of bacterial infection in vivo and may have significant clinical implications for understanding the etiology of recurrent UTIs and providing cellular targets for therapeutic intervention.
Materials and Methods
Mice. Experiments were performed using protocols approved by the animal studies committee of the Washington University School of Medicine (Animal Welfare Assurance A-3381-01). The Atg16L1 HM2 strain (Atg16L1 
